Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors

Front Oncol. 2023 Mar 28:13:1180650. doi: 10.3389/fonc.2023.1180650. eCollection 2023.

Authors

Andrea Cavazzoni¹, Arianna Palladini²

Affiliations

¹ Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Department of Molecular Medicine, University of Pavia, Pavia, Italy.

No abstract available

Keywords: CDK; Rb; combination; pre-clinical; solid tumors.

Publication types

Editorial